HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers

Overview of attention for article published in Cancer Immunology, Immunotherapy, October 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 1 X user

patent: 3 patents

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,742 followers.

HER-2/neu vaccine-primed autologous T-cell infusions for treatment of advanced stage HER-2/neu cancers http://t.co/ySzeaaQjth #springerlink

Reply Repost Favourite